Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biotechnol Lett. 2006 Jun;28(11):837-41. Epub 2006 May 31.

Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum.

Author information

  • 1College of Life Science, South China Normal University, Guangzhou 510631, PR China. liyq9168@hotmail.com

Abstract

Ganoderic acid, from Ganoderma lucidum, at 8 microg/ml inhibited replication of hepatitis B virus (HBV) in HepG2215 cells over 8 days. Production of HBV surface antigen and HBV e antigen were 20 and 44% of controls without ganoderic acid. Male KM mice were significantly protected from liver injury, induced with carbon tetrachloride, by treatment with ganoderic acid at 10 mg and 30 mg/kg x d (by intravenous injection) 7 days. Ganoderic acid at the same dosage also significantly protected the mice from liver injury induced by M. bovis BCG plus lipopolysaccharide (from Escherichia coli 0127:B8).

PMID:
16786250
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk